Scope of the Study
ELISA (Enzyme-Linked Immunosorbent Assay) is a plate-based assay technique, which is designed for detecting and quantifying peptides, proteins, antibodies and hormones. Competitive ELISA is also known as inhibition ELISA is a surface/plate based assay where the plate is coated with capture antibodies reactive to the molecule of interest. Primary antibody (unlabeled) is incubated with sample antigen. Antibody-antigen complexes are added to 96-well plates which are pre-coated with the same antigen. Unbound antibody is removed by the washing the plate. The secondary antibody that is specific to the primary antibody and conjugated with an enzyme is added. A substrate is added and remaining enzymes elicit a chromogenic or fluorescent signal. The applications of ELISA include HIV infection, pregnancy tests and measurement of cytokines, soluble proteins etc.
The market study is being classified by Type (ELISA Sets and ELISA Kits), by Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Development and Pharmaceutical Industry, Transplantation and Other) and major geographies with country level break-up.
Bio-Rad Laboratories (United States), Fisher Scientific (United States), Cell Biolabs, Inc. (United States), Enzo Life Sciences, Inc. (United States), Sino Biological Inc. (United States), BioVision, Inc. (United States), Invitrogen (United States), Hycult Biotech (Netherlands), Biomerieux (France) and ALPCO (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are BioLegend, Inc. (United States), ZEUS Scientific, Inc. (United States), Shenzhen YHLO Biotech Co., Ltd. (China) and Abnova (China).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Competitive ELISA market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Competitive ELISA market by Type, Application and Region.
On the basis of geography, the market of Competitive ELISA has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by ELISA, the sub-segment i.e. Direct ELISA will boost the Competitive ELISA market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Prevalence of Infectious Disease Such As HIV
- Increased Awareness Regarding Diagnosis of Cancer and Autoimmune Diseases
- Emergence of Cost Effective Technologies and Laboratory Automation
- Substitution by New Technologies
- Increasing the Need for Accurate and Early Disease Diagnosis
- Rising Geriatric Population
- Lack of Awareness in Developing Countries
On 2nd November 2016, Enzo Life Sciences introduced immunoassay, IL-6 (human), high sensitivity ELISA kit, the most sensitive IL-6 ELISA on the market.
Key Target AudienceCompetitive ELISA Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Research Professionals, Government Body & Associations and End-user
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase